Ohio Innovation Fund was among the shareholders who returned for Enable Injections’ latest round.
Enable Injections, a US-based medical device developer, has raised $215m in a series C round featuring Ohio Innovation Fund, the venture capital vehicle co-founded by Ohio State University, Ohio University and Kent State University. Magnetar Capital led the round, which also attracted Cincinnati Children’s Hospital Medical Center, CincyTech, Cintrifuse, GCM Grosvenor, Squarepoint Capital, Woody Creek…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
